Uploaded By:  Janine Ballesteros Submitted By:  Janine Ballesteros Case Study:  No Biolidics wil...

THE following companies saw new developments that may affect trading of their securities on Thursday:

SINGAPORE-BASED cancer-diagnostics company Biolidics said on Wednesday that it has entered a collaboration agreement with Hangzhou-based LC-Bio to develop cancer-diagnostic solutions.

Uploaded By:  Janine Ballesteros Submitted By:  Janine Ballesteros Case Study:  No This follows ...

CATALIST-listed company Biolidics issued a statement on Friday to explain why its deal with Aytu Bioscience to distribute its novel conronavirus antibody test kits in the US has now been scrapped. 

BIOLIDICS shares sank 22 per cent on Monday after the Catalist-listed firm announced on Sunday that it had mutually agreed with Aytu BioScience to terminate a distribution agreement for its Covid-19 antibody test kits in the US, amid increased competition for such kits.

Uploaded By:  Janine Ballesteros Submitted By:  Janine Ballesteros Case Study:  No The company u...

BIOLIDICS has signed a non-binding letter of intent (LOI) with Aytu BioScience to jointly develop a new test kit with broader use outside of laboratory or clinical settings.

SINGAPORE (June 23): CGS-CIMB Research is rating the medical equipment and services industry “overweight” amid the Covid-19 pandemic. In a Monday report, lead analyst Ong Khang Chuen says, “As the world grapples with Covid-19, it faces a new normal until an effective and widely-available vacci...

SINGAPORE (May 31): Clearbridge Health said its indirectly-held subsidiary in Indonesia has been sued by a joint venture partner in Jakarta, This partner, PT Tirta Medika Nusantara (TMN), claims that a certain notarial deed has been made unlawfully, and as such, seeking damages of IDR 1.06 trillion ...